| MSD Merck Sharp & Dohme AG - Noxafil, Suspension zum Einnehmen |
| 57843 | | 01 | | Noxafil | | Suspension zum Einnehmen | | J02AC04 | | Posaconazole | | 02.03.2007 | | |
|
| Composition |
| posaconazolum 40 mg, polysorbatum 80, glucosum liquidum, arom.: vanillinum et alia, conserv.: E 211, alcohol benzylicus, excipiens ad suspensionem pro 1 ml. |
| Packungsbestandteile |
| Suspension (oral) | | | | | | | | Active Agent | Dose |
|---|
| Posaconazole | 40 mg |
| | BAG: Active Agent | Dose |
|---|
| Posaconazole | 40 mg |
| | | | Inactive agents | | additional_information |
|---|
| Alcohol Benzylicus | | | | Alia | | | | E 211 | | conserv. | | Glucosum Liquidum | | | | Polysorbatum 80 | | | | Vanilline | | arom. |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 105 ml | 564.45 | 627.15 | B | SL | No |
|
